Dose conversion to IPX066 in advanced Parkinson's disease patients treated with carbidopa-levodopa-entacapone

被引：0
|
作者：
Hsu, A.
Khanna, S.
Kell, S.
Espay, A.
Gil, R.
Singer, C.
Gupta, S.
机构：
来源：
MOVEMENT DISORDERS | 2013年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
416
引用
收藏
页码：S149 / S149
页数：1
相关论文
共 50 条
  • [41] Conversion from sustained release carbidopa/levodopa to carbidopa/levodopa/entacapone (Stalevo) in Parkinson disease patients
    Lyons, KE
    Pahwa, R
    CLINICAL NEUROPHARMACOLOGY, 2006, 29 (02) : 73 - 76
  • [42] Levodopa/carbidopa/entacapone in Parkinson's disease
    Seeberger, Lauren C.
    Hauser, Robert A.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2009, 9 (07) : 929 - 940
  • [43] Exploratory analysis of IPX066 on motor fluctuations in advanced Parkinson's disease (PD)
    Hsu, A.
    O'Connell, M.
    Khanna, S.
    Gupta, S.
    MOVEMENT DISORDERS, 2012, 27 : S122 - S122
  • [44] Levodopa half-life with additional carbidopa in Parkinson's disease (PD) patients treated with carbidopa/levodopa and entacapone
    Parashos, SA
    Wielinski, CL
    Peterson, SM
    Brundage, RC
    MOVEMENT DISORDERS, 2005, 20 : S89 - S90
  • [45] Dosing Patterns during Conversion to IPX066, Extended-Release Carbidopa-Levodopa (ER CD-LD), in Parkinson's Disease with Motor Fluctuations
    Morgan, John C.
    Dhall, Rohit
    Rubens, Robert
    Khanna, Sarita
    Gupta, Suneel
    PARKINSONS DISEASE, 2018, 2018
  • [46] PROFILE OF PATIENTS WITH ADVANCED PARKINSON'S DISEASE TREATED WITH LEVODOPA-ENTACAPONE-CARBIDOPA INTESTINAL GEL (LECIG)
    Szasz, J.
    Constantin, V.
    Kis, K. Orban
    Bataga, S.
    Neagoe, R.
    Ciorba, M.
    Krisztina, K.
    Mihaly, I.
    Szatmari, S.
    PARKINSONISM & RELATED DISORDERS, 2024, 122
  • [47] Comparison of IPX066, a Novel Carbidopa-Levodopa (CD-LD) Extended-Release Formulation, and CD-LD-Entacapone (CLE) in Advanced Parkinson's Disease (ASCEND-PD Trial)
    Stocchi, Fabrizio
    Dillmann, Ulrich
    Ellenbogen, Aaron
    Hsu, Ann
    Khanna, Sarita
    Rubens, Robert
    Liang, Grace
    Gupta, Suneel
    NEUROLOGY, 2012, 78
  • [48] PHARMACODYNAMICS OF IPX066, AN EXTENDED-RELEASE CAPSULE FORMULATION OF CARBIDOPA-LEVODOPA (CD-LD), IN PATIENTS WITH EARLY PARKINSON'S DISEASE: A DISEASE PROGRESSION MODEL
    Mao, Z.
    Hsu, A.
    Gupta, S.
    Modi, N. B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S81 - S81
  • [49] Levodopa/carbidopa/entacapone in early Parkinson's disease
    Reactions Weekly, 2020, 1798 (1) : 10 - 10
  • [50] PATIENT SELF-ASSESSMENTS IN ADVANCED PARKINSON'S DISEASE WITHIN UPDRS AND "OFF" TIME SUBGROUPS: COMPARISON OF IPX066 WITH IMEDIATE-RELEASE CARBIDOPA-LEVODOPA
    Rubens, R.
    Rustay, N. R.
    Khanna, S.
    Kell, S.
    Gupta, S.
    VALUE IN HEALTH, 2015, 18 (03) : A279 - A279
12345